Nuzenio

Fierce Pharma Lilly

Fierce Pharma Lilly news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 2 publisher sources 100/100 entity strength

Latest news

The Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2 - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 07:00:00 GMTLilly’s obesity pill Foundayo ‘disappointed’ in Q2, as injectables continue to boom - Fierce PharmaFierce Pharma · Wed, 05 Aug 2026 15:42:35 GMTLilly drops another gene therapy trial from $1B Prevail buyout - Fierce BiotechFierce Biotech · Wed, 05 Aug 2026 13:10:00 GMTNovo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data - Fierce BiotechFierce Biotech · Wed, 05 Aug 2026 12:00:00 GMTLilly, Resilience commit $750M to boost US diabetes, obesity med production - Fierce PharmaFierce Pharma · Thu, 30 Jul 2026 07:00:00 GMTEli Lilly tops new biopharma ranking on launch success, development speed - Fierce BiotechFierce Biotech · Tue, 28 Jul 2026 17:00:12 GMT

Timeline

Fri, 07 Aug 2026 07:00:00 GMTThe Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2 - Fierce Pharma
Wed, 05 Aug 2026 15:42:35 GMTLilly’s obesity pill Foundayo ‘disappointed’ in Q2, as injectables continue to boom - Fierce Pharma
Wed, 05 Aug 2026 13:10:00 GMTLilly drops another gene therapy trial from $1B Prevail buyout - Fierce Biotech
Wed, 05 Aug 2026 12:00:00 GMTNovo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data - Fierce Biotech
Thu, 30 Jul 2026 07:00:00 GMTLilly, Resilience commit $750M to boost US diabetes, obesity med production - Fierce Pharma
Tue, 28 Jul 2026 17:00:12 GMTEli Lilly tops new biopharma ranking on launch success, development speed - Fierce Biotech

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Fierce Pharma Lilly.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.